Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations.

Mutations in the high-affinity sulfonylurea receptor (SUR)-1 cause one of the severe recessively inherited diffuse forms of congenital hyperinsulinism or, when associated with loss of heterozygosity, focal adenomatosis. We hypothesized that SUR1 mutations would render the beta-cell insensitive to sulfonylureas and to glucose. Stimulated insulin responses were compared among eight patients with diffuse hyperinsulinism (two mutations), six carrier parents, and ten normal adults. In the patients with diffuse hyperinsulinism, the acute insulin response to intravenous tolbutamide was absent and did not overlap with the responses seen in either adult group. There was positive, albeit significantly blunted, acute insulin response to intravenous dextrose in the patients with diffuse hyperinsulinism. Graded infusions of glucose, to raise and then lower plasma glucose concentrations over 4 h, caused similar rises in blood glucose but lower peak insulin levels in the hyperinsulinemic patients. Loss of acute insulin response to tolbutamide can identify children with diffuse SUR1 defects. The greater response to glucose than to tolbutamide indicates that ATP-sensitive potassium (KATP) channel-independent pathways are involved in glucose-mediated insulin release in patients with diffuse SUR1 defects. The diminished glucose responsiveness suggests that SUR1 mutations and lack of KATP channel activity may contribute to the late development of diabetes in patients with hyperinsulinism independently of subtotal pancreatectomy.

[1]  L. Aguilar-Bryan,et al.  Sur1 Knockout Mice , 2000, The Journal of Biological Chemistry.

[2]  C. Junien,et al.  Genetics of neonatal hyperinsulinism , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[3]  R. M. Shepherd,et al.  Hyperinsulinism of infancy: towards an understanding of unregulated insulin release , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[4]  J. Bryan,et al.  Sulfonylurea receptors: ABC transporters that regulate ATP-sensitive K(+) channels. , 1999, Biochimica et biophysica acta.

[5]  C. Stanley,et al.  Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. , 1999, Diabetes.

[6]  A. Babenko,et al.  The C Terminus of SUR1 Is Required for Trafficking of KATP Channels* , 1999, The Journal of Biological Chemistry.

[7]  C. Stanley,et al.  Congenital hyperinsulinism and the surgeon: lessons learned over 35 years. , 1999, Journal of pediatric surgery.

[8]  T. Schermerhorn,et al.  cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. , 1999, Diabetes.

[9]  J. Bryan,et al.  ATP-sensitive potassium channels. , 1999, Methods in enzymology.

[10]  M. Permutt,et al.  Hyperinsulinism: molecular aetiology of focal disease , 1998, Archives of disease in childhood.

[11]  C. Junien,et al.  Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. , 1998, The Journal of clinical investigation.

[12]  C. Stanley,et al.  Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. , 1998, The New England journal of medicine.

[13]  M. Dunne,et al.  Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets. , 1998, Diabetes.

[14]  L. Philipson,et al.  Characterization of a Ca2+ Release-activated Nonselective Cation Current Regulating Membrane Potential and [Ca2+] i Oscillations in Transgenically Derived β-Cells* , 1998, The Journal of Biological Chemistry.

[15]  F M Matschinsky,et al.  Familial hyperinsulinism caused by an activating glucokinase mutation. , 1998, The New England journal of medicine.

[16]  A. Babenko,et al.  A view of sur/KIR6.X, KATP channels. , 1998, Annual review of physiology.

[17]  M. Permutt,et al.  Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant. , 1998, The Journal of pediatrics.

[18]  K. Kunjilwar,et al.  Toward understanding the assembly and structure of KATP channels. , 1998, Physiological reviews.

[19]  M. Permutt,et al.  A Nonsense Mutation in the Inward Rectifier Potassium Channel Gene, Kir6.2, Is Associated With Familial Hyperinsulinism , 1997, Diabetes.

[20]  R. Filler,et al.  Endogenous hyperinsulinism: diagnosis, management, and long-term follow-up. , 1997, Seminars in pediatric surgery.

[21]  C. Stanley,et al.  Hyperinsulinism in infants and children. , 1997, Pediatric clinics of North America.

[22]  C. Polychronakos,et al.  An autosomal dominant form of familial persistent hyperinsulinemic hypoglycemia of infancy, not linked to the sulfonylurea receptor locus. , 1997, The Journal of clinical endocrinology and metabolism.

[23]  R. M. Shepherd,et al.  Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. , 1997, The New England journal of medicine.

[24]  M. Permutt,et al.  Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. , 1996, Human molecular genetics.

[25]  A. Hattersley,et al.  Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects With Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12 , 1996, Diabetes.

[26]  E. Lightner,et al.  Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. , 1996, Human molecular genetics.

[27]  L. Philipson,et al.  K+ Channels: Generating Excitement in Pancreatic β-Cells , 1996, Diabetes.

[28]  M. Permutt,et al.  Adenosine Diphosphate as an Intracellular Regulator of Insulin Secretion , 1996, Science.

[29]  J. Gromada,et al.  Glucose stimulates voltage- and calcium-dependent inositol trisphosphate production and intracellular calcium mobilization in insulin-secreting beta TC3 cells. , 1996, The Biochemical journal.

[30]  L. Philipson,et al.  K+ channels: generating excitement in pancreatic beta-cells. , 1996, Diabetes.

[31]  G. Cote,et al.  The molecular basis for familial persistent hyperinsulinemic hypoglycemia of infancy. , 1996, Proceedings of the Association of American Physicians.

[32]  J. Inazawa,et al.  Reconstitution of IKATP: An Inward Rectifier Subunit Plus the Sulfonylurea Receptor , 1995, Science.

[33]  J. Bryan,et al.  Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. , 1995, Science.

[34]  B. Glaser,et al.  Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. , 1995, The Journal of clinical endocrinology and metabolism.

[35]  Homozygosity mapping, to chromosome 11p, of the gene for familial persistent hyperinsulinemic hypoglycemia of infancy. , 1995, American journal of human genetics.

[36]  佐藤 吉彦.  Dual functional role of membrane depolarization/Ca[2+] influx in rat pancreatic B-cell , 1995 .

[37]  T. Yada,et al.  Interplay of glucose-stimulated Ca2+ sequestration and acetylcholine-induced Ca2+ release at the endoplasmic reticulum in rat pancreatic beta-cells. , 1995, Cell calcium.

[38]  I. Dukes,et al.  Depletion of intracellular Ca2+ stores activates a maitotoxin-sensitive nonselective cationic current in beta-cells. , 1994, The Journal of biological chemistry.

[39]  H. Luthman,et al.  Glucose Potentiation of Arginine-Induced Insulin Secretion is Impaired in Subjects With a Glucokinase Glu256Lys Mutation , 1994, Diabetes.

[40]  I. Dukes,et al.  Thapsigargin inhibits the glucose-induced decrease of intracellular Ca2+ in mouse islets of Langerhans. , 1994, The American journal of physiology.

[41]  J. Rice,et al.  Familial hyperinsulinism maps to chromosome 11p14–15.1, 30 cM centromeric to the insulin gene , 1994, Nature Genetics.

[42]  K. Clément,et al.  Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. , 1994, The Journal of clinical investigation.

[43]  J. Halter,et al.  Abnormal Insulin Secretion, Not Insulin Resistance, Is the Genetic or Primary Defect of MODY in the RW Pedigree , 1994, Diabetes.

[44]  A. Yates,et al.  Stimulation of insulin secretion by glucose in the absence of diminished potassium (86Rb+) permeability. , 1992, Biochemical pharmacology.

[45]  M. Komatsu,et al.  Dual Functional Role of Membrane Depolarization/Ca2+ Influx in Rat Pancreatic B-Cell , 1992, Diabetes.

[46]  P. Gilon,et al.  Evidence that glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells. , 1992, The Journal of clinical investigation.

[47]  F. Service,et al.  Diagnostic interpretation of the intravenous tolbutamide test for insulinoma. , 1989, Mayo Clinic proceedings.

[48]  R. Bergman,et al.  Defects in β-Cell Function and Insulin Sensitivity in Normoglycemic Streptozocin-Treated Baboons: A Model of Preclinical Insulin-Dependent Diabetes* , 1988 .

[49]  R. Bergman,et al.  Defects in beta-cell function and insulin sensitivity in normoglycemic streptozocin-treated baboons: a model of preclinical insulin-dependent diabetes. , 1988, The Journal of clinical endocrinology and metabolism.

[50]  R. Robertson,et al.  A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics. , 1981, Metabolism: clinical and experimental.

[51]  E. Cerasi,et al.  Potentiation and inhibition of insulin release in man following priming with glucose and with arginine--effect of somatostatin. , 1979, Acta endocrinologica.

[52]  R. Ehrlich,et al.  Tolbutamide tolerance test and plasma-insulin response in children with idiopathic hypoglycemia. , 1967, The Journal of pediatrics.